Showing results (921-930 of 1,610) with videos related to
Sort By:
Pageof 161
Archives of Osteoporosis|May 21, 2020
The effects of patient and disease-related factors on the quality of life in patients with hypoparathyroidismSema Hepsen, Pinar Akhanli, Davut Sakiz, et al.Archives of Osteoporosis|November 10, 2022
Attributable disease burden related to low bone mineral density in Iran from 1990 to 2019: results from the Global Burden of Disease 2019Mohammadreza Azangou-Khyavy, Sahar Saeedi Moghaddam, Esmaeil Mohammadi, et al.Archives of Osteoporosis|June 4, 2021
Development of prediction model for osteoporotic vertebral compression fracture screening without using clinical risk factors, compared with FRAX and other previous modelsPongsthorn Chanplakorn, Thamrong Lertudomphonwanit, Nuttorn Daraphongsataporn, et al.Archives of Osteoporosis|June 4, 2021
Fast kilovoltage (KV)-switching dual-energy CT virtual noncalcium technique using different reconstruction kernels for identifying acute and chronic vertebral compression fracturesLuyou Yan, Zeya Zhong, Hui Gao, et al.Archives of Osteoporosis|June 5, 2021
Bisphosphonate treatment and the risk of atypical femoral fracture among patients participating in a Fracture Liaison Service of a tertiary medical centerNoa Bareli, Roni Gat, Victoria Makarov, et al.Archives of Osteoporosis|June 8, 2021
A country-specific FRAX model for BotswanaM Kebaetse, S Nkhwa, M Mogodi, et al.Archives of Osteoporosis|December 17, 2022
An assessment of intervention thresholds for high fracture risk in ChileEnrique Lopez Gavilanez, Imaicela N Luis, Navarro G Mario, et al.Archives of Osteoporosis|December 17, 2022
Osteoporotic fracture admissions compared to other major medical admissions in Irish public hospitalsD O 'Sullivan, C Silke, B Whelan, et al.Archives of Osteoporosis|January 11, 2023
Utilization patterns and factors associated with persistence of new users of anti-osteoporosis treatment in Denmark: a population-based cohort studyAlma B Pedersen, Nickolaj Risbo, George Kafatos, et al.Archives of Osteoporosis|January 9, 2023
The clinical effectiveness of denosumab (Prolia®) in patients with hormone-sensitive cancer receiving endocrine therapy, compared to bisphosphonates, selective estrogen receptor modulators (SERM), and placebo: a systematic review and network meta-analysisKonstance Nicolopoulos, Magdalena Ruth Moshi, Danielle Stringer, et al.Pageof 161